October 2-3, 2018
San Diego and San Francisco

At Clinipace, we take pride in building strong relationships and doing what it takes to deliver clinical development services and solutions that successfully move your drug candidate to market.

Join Sharon Moore, chief medical officer; Nikolas Burlew, executive vice president of regulatory and strategic development global consulting; and Dawn Sauro, chief development officer, for a panel discussion and workshop about Multinational Development Strategies for Emerging Therapies. Whether you need regulatory or clinical development expertise for your multinational drug development program, WE WILL BRING IT. Here’s how:

  • Managing adaptive design trials in the age of real-time access to clinical data
  • Navigating recent changes in the global regulatory landscape
  • Key considerations for clinical development of advanced therapeutics including new GCP requirements for ATMPs, supply chain and testing challenges
  • The impact of ICH guidelines E5 and E17 on the design of multinational clinical development programs

This event will be hosted at two different locations on October 2 and October 3. When registering please select which date and location you’ll be able to attend.

SAN DIEGO

Marriott San Diego La Jolla
4240 La Jolla Village Dr.
La Jolla, CA 92037
October 2, 2018
4:00 – 6:30 p.m.

SAN FRANCISCO

Embassy Suites Hotel
250 Gateway Blvd.
South San Francisco, CA 94080
October 3, 2018
4:00 – 6:30 p.m.

Add to Calendar

Back to Events